Cite
Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial.
MLA
How, Jeffrey A., et al. “Pembrolizumab in Vaginal and Vulvar Squamous Cell Carcinoma: A Case Series from a Phase II Basket Trial.” Scientific Reports, vol. 11, no. 1, Feb. 2021, pp. 1–7. EBSCOhost, https://doi.org/10.1038/s41598-021-83317-7.
APA
How, J. A., Jazaeri, A. A., Soliman, P. T., Fleming, N. D., Gong, J., Piha-Paul, S. A., Janku, F., Stephen, B., & Naing, A. (2021). Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial. Scientific Reports, 11(1), 1–7. https://doi.org/10.1038/s41598-021-83317-7
Chicago
How, Jeffrey A., Amir A. Jazaeri, Pamela T. Soliman, Nicole D. Fleming, Jing Gong, Sarina A. Piha-Paul, Filip Janku, Bettzy Stephen, and Aung Naing. 2021. “Pembrolizumab in Vaginal and Vulvar Squamous Cell Carcinoma: A Case Series from a Phase II Basket Trial.” Scientific Reports 11 (1): 1–7. doi:10.1038/s41598-021-83317-7.